Cirrhosis

Cirrhosis is a condition in which the liver slowly deteriorates and malfunctions due to chronic injury. Scar tissue replaces healthy liver tissue, partially blocking the flow of blood through the liver.

What is Cirrhosis?

Cirrhosis is a severe form of liver disease wherein normal liver tissue is replaced by scar tissue (fibrous tissue).

What Causes Cirrhosis?

Managing and Treating Cirrhosis

Liver Disease Symptoms

Owlstone Medical releases positive study results on use of breath biopsy for better liver disease diagnosis

Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates the use of exhaled limonene as a breath biomarker to measure liver function and stage liver disease.

From Owlstone Medical Ltd 23 Sep 2020

Drug for liver cirrhosis shows potential to treat dementia and motor neuron disease

A drug used to treat cirrhosis of the liver may be an effective treatment for a form of Dementia and motorneuron disease, scientists have discovered.

14 Sep 2020

Study identifies gene that could decrease chances of developing alcoholic cirrhosis

Researchers at Indiana University School of Medicine are learning more about how a person's genes play a role in the possibility they'll suffer from alcoholic cirrhosis with the discovery of a gene that could make the disease less likely.

12 Sep 2020

Study identifies three clinical course variations in patients with acute decompensated cirrhosis

When the body can no longer compensate the gradual failure of the liver caused by liver cirrhosis, there is a high risk of acute decompensated liver cirrhosis.

27 Aug 2020

New discovery could help protect the liver from fructose-induced diseases

A team of international researchers including Monash University academics has discovered that, contrary to previous belief, fructose causes liver toxicity by changing the barrier function of the intestine.

27 Aug 2020

Researchers identify how promising therapy may work to improve adverse effects of NAFLD

A team led by researchers at Massachusetts General Hospital (MGH) has taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease.

26 Aug 2020

Researchers identify three forms of disease progression for acute decompensated liver cirrhosis

When the body can no longer compensate the gradual failure of the liver caused by liver cirrhosis, there is a high risk of acute decompensated liver cirrhosis.

26 Aug 2020

Excessive fructose consumption can result in non-alcoholic fatty liver disease

Excessive consumption of fructose -; a sweetener ubiquitous in the American diet -; can result in non-alcoholic fatty liver disease (NAFLD), which is comparably abundant in the United States.

24 Aug 2020

New insights into how high-protein diet protects against fatty liver

Non-alcoholic fatty liver disease is the most common chronic liver disease in the world, with sometimes life-threatening consequences.

18 Aug 2020

TGen review: Postmenopausal women at higher risk for developing NALFD

A review article authored by a researcher at the Translational Genomics Research Institute, an affiliate of City of Hope, suggests that following menopause, women are at higher risk for developing nonalcoholic fatty liver disease, a chronic condition caused by the build-up of excess fat in the liver not caused by alcohol.

14 Aug 2020

Natural controllers shed light on immunity mechanisms against hepatitis B

Infections in humans caused by the hepatitis B virus (HBV) represent a major public health problem. Despite the availability of effective protective vaccines, more than 250 million individuals worldwide are chronically infected according to WHO estimates.

13 Aug 2020

Scientists explore mechanisms involved in the development of liver disease

Metabolic fatty liver disease, known as non-alcoholic fatty liver disease, is one of the most common causes of liver disease in Western countries and covers a spectrum of disorders.

6 Aug 2020

European Commission approves first drug for hepatitis D

What started off as basic research 25 years ago has now lead to a successfully approved drug: The entry blocker bulevirtide (brand name Hepcludex, formerly known as Myrcludex B), jointly developed by researchers from Heidelberg University Hospital (UKHD) and the Medical Faculty of Heidelberg, the DZIF and other partners, has now been approved by the European Commission.

5 Aug 2020

Understanding the causal relationships between diabetes, obesity and NAFLD

Diabetes, obesity and nonalcoholic fatty liver disease (NAFLD) are all common diseases that can lead to serious health implications.

31 Jul 2020

Aerobic exercise may be more important for improvement in patients with fatty liver diseases

A new study from Trinity College Dublin highlights that fitness may be a more important clinical endpoint for improvement in patients with fatty liver diseases during exercise trials, rather than weight loss.

29 Jul 2020

Study estimates the past and present burden of viral hepatitis through blood transfusions

What is the incidence of viral hepatitis caused by blood transfusions before and after Sweden introduced screening of blood in the early 1990s? In an article published in Eurosurveillance ahead of World Hepatitis Day on 28 July, the authors also try to estimate how many people of those who were infected with hepatitis B and C through blood transfusion still live with undiagnosed hepatitis.

23 Jul 2020

Non-invasive algorithm predicts complications in patients following recovery from hepatitis C

The chronic viral inflammation of the liver that occurs in hepatitis C results in the formation of inflexible scar tissue in the form of fibrosis/cirrhosis of the liver. This impedes the flow of blood through the organ, with resulting hypertension in the portal vein.

23 Jul 2020

Cirrhosis

Overview

What Causes Cirrhosis?

Managing and Treating Cirrhosis

Liver Disease Symptoms

Latest Cirrhosis News and Research

Owlstone Medical releases positive study results on use of breath biopsy for better liver disease diagnosis

Drug for liver cirrhosis shows potential to treat dementia and motor neuron disease

Study identifies gene that could decrease chances of developing alcoholic cirrhosis

Study identifies three clinical course variations in patients with acute decompensated cirrhosis

New discovery could help protect the liver from fructose-induced diseases

Researchers identify how promising therapy may work to improve adverse effects of NAFLD

Researchers identify three forms of disease progression for acute decompensated liver cirrhosis

Excessive fructose consumption can result in non-alcoholic fatty liver disease

New insights into how high-protein diet protects against fatty liver

TGen review: Postmenopausal women at higher risk for developing NALFD

Natural controllers shed light on immunity mechanisms against hepatitis B

Scientists explore mechanisms involved in the development of liver disease

European Commission approves first drug for hepatitis D

Understanding the causal relationships between diabetes, obesity and NAFLD

Aerobic exercise may be more important for improvement in patients with fatty liver diseases

Study estimates the past and present burden of viral hepatitis through blood transfusions

Non-invasive algorithm predicts complications in patients following recovery from hepatitis C

Fat cell hormone enhances therapeutic potential of MSC therapy

Experts develop a simple questionnaire to raise awareness about managing liver disease

HCV testing and treatment at federally qualified health centers can be cost-fffective

Discovering a molecule that could replicate SARS-CoV-2

Providing Personalized Care for Bleeding Disorders

Delayed immune responses may be responsible for COVID-19 mortality rates

Cirrhosis

Overview

Latest Cirrhosis News and Research

Newsletters you may be interested in